ALD-301, bone marrow-derived cells for critical limb ischemia
ALD products are bone marrow-derived cells which express high levels of aldehyde dehydrogenase (ALDH). These cells are used to treat critical limb ischemia. The treatment improved blood flow and clinical status. The therapy appears to be safe, without significant side effects or adverse events.
Read More
Product Information for
ALD-301, bone marrow-derived cells for critical limb ischemia
Links related to the product - may include a range of information sources (e.g., press releases, websites, patents) related to the specific cell therapy application.
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access